TRUEX PAUL F
Insider CIK 1120362 · CBAY Director · ANTH President and Chief Executive, Director · TSRX Director · MIST Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MIST Milestone Pharmaceuticals | M Exercise deriv | 2022-05-31 | 2022-06-01 | 822 | — | $0 | 117 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise deriv | 2022-05-31 | 2022-06-01 | 45,072 | — | $0 | 0 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise deriv | 2022-05-31 | 2022-06-01 | 8,016 | — | $0 | 0 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise deriv | 2022-05-31 | 2022-06-01 | 22,870 | — | $0 | 2,659 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise | 2022-05-31 | 2022-06-01 | 8,016 | $1.12 | $9.0K | 8,016 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise | 2022-05-31 | 2022-06-01 | 45,072 | $1.54 | $69.4K | 53,088 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise | 2022-05-31 | 2022-06-01 | 22,870 | $1.54 | $35.2K | 75,958 | SEC↗ |
| MIST Milestone Pharmaceuticals | M Exercise | 2022-05-31 | 2022-06-01 | 822 | $2.66 | $2.2K | 76,780 | SEC↗ |
| MIST Milestone Pharmaceuticals | P Buy | 2022-05-31 | 2022-06-01 | 5,000 | $5.60 | $28.0K | 81,780 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2021-06-14 | 2021-07-29 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2021-01-26 | 2021-01-28 | 32,000 | — | $0 | 32,000 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2020-06-05 | 2020-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2020-05-15 | 2020-05-19 | 49,245 | — | $0 | 49,245 | SEC↗ |
| MIST Milestone Pharmaceuticals | A Award deriv | 2019-11-12 | 2019-11-14 | 4,000 | — | $0 | 4,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2019-01-29 | 2019-01-31 | 27,705 | — | $0 | 27,705 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2018-01-24 | 2018-01-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 84,705 | — | $0 | 84,705 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2018-01-05 | 2018-01-09 | 84,705 | — | $0 | 84,705 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-09-22 | 2017-09-26 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2017-09-07 | 2017-09-07 | 5,000 | $1.34 | $6.7K | 16,793 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-06-28 | 2017-06-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | J Other deriv | 2017-05-19 | 2017-05-19 | 1,369 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | J Other deriv | 2017-05-19 | 2017-05-19 | 84,376 | — | $0 | 0 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2017-01-19 | 2017-01-23 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | J Other deriv | 2016-12-02 | 2016-12-06 | 170,000 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | J Other deriv | 2016-12-02 | 2016-12-06 | 180,000 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2016-09-20 | 2016-09-22 | 5,008 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2016-09-20 | 2016-09-22 | 5,008 | $2.08 | $10.4K | 5,008 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2016-09-20 | 2016-09-22 | 5,008 | — | $0 | 94,345 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-06-09 | 2016-06-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| CBAY CymaBay Therapeutics, Inc. | A Award deriv | 2016-04-26 | 2016-04-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2016-02-12 | 2016-02-16 | 15,816 | — | $0 | 15,816 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-09-17 | 2015-09-18 | 180,000 | — | $0 | 180,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2015-09-17 | 2015-09-18 | 170,000 | — | $0 | 170,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2014-12-31 | 2015-01-02 | 12,500 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2014-12-31 | 2015-01-02 | 12,500 | — | $0 | 89,337 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-12-30 | 2015-01-02 | 330,000 | — | $0 | 330,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2014-06-30 | 2014-07-01 | 2,000 | $2.08 | $4.2K | 13,845 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2014-06-30 | 2014-07-01 | 699 | $3.39 | $2.4K | 14,709 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2014-06-30 | 2014-07-01 | 16,500 | — | $0 | 62,128 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | J Other | 2014-06-30 | 2014-07-01 | 14,709 | — | $0 | 14,709 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-03-25 | 2014-03-27 | 18,440 | — | $0 | 18,440 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2014-03-25 | 2014-03-28 | 18,440 | — | $0 | 18,440 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2014-03-25 | 2014-03-27 | 7,622 | $3.30 | $25.2K | 9,333 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 6,250 | $3.30 | $20.6K | 597,787 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-27 | 3,864 | — | $0 | 13,197 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2014-03-25 | 2014-03-28 | 1,352 | $3.30 | $4.5K | 11,845 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2014-03-25 | 2014-03-28 | 3,864 | — | $0 | 13,197 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2014-03-25 | 2014-03-28 | 7,622 | $3.30 | $25.2K | 9,333 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $5.24 | $62.9K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $10.00 | $120.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,403 | $12.21 | $151.4K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 15,000 | $5.73 | $86.0K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer deriv | 2013-09-11 | 2013-09-13 | 12,000 | $8.45 | $101.4K | 0 | SEC↗ |
| TSRX Trius Therapeutics Inc | D To issuer | 2013-09-11 | 2013-09-13 | 11,270 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2013-06-30 | 2014-03-28 | 6,250 | $3.30 | $20.6K | 80,190 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2013-05-21 | 2013-05-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2013-05-21 | 2013-05-21 | 100,000 | — | $0 | 591,537 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2013-05-17 | 2013-05-21 | 5,400,000 | — | $0 | 5,400,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2013-03-25 | 2013-03-27 | 135,644 | — | $0 | 135,644 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2013-01-07 | 2013-01-08 | 66,412 | — | $0 | 0 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2013-01-07 | 2013-01-08 | 66,412 | — | $0 | 691,537 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2013-01-03 | 2013-01-08 | 17,454 | $0.69 | $12.0K | 66,412 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | P Buy | 2012-06-29 | 2012-07-02 | 20,000 | $0.76 | $15.2K | 645,125 | SEC↗ |
| TSRX Trius Therapeutics Inc | A Award deriv | 2012-05-22 | 2012-05-24 | 12,000 | — | $0 | 12,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2012-03-30 | 2012-04-03 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-02-15 | 2012-02-17 | 15,000 | $7.84 | $117.6K | 625,125 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2012-02-06 | 2012-02-06 | 37,984 | — | $0 | 79,755 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise | 2012-01-31 | 2012-02-02 | 20,000 | $0.26 | $5.2K | 640,125 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | G Gift | 2012-01-27 | 2012-02-02 | 7,000 | — | $0 | 620,125 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-01-17 | 2012-01-19 | 15,000 | $6.75 | $101.3K | 627,125 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise deriv | 2011-01-31 | 2012-02-02 | 20,000 | — | $0 | 262,826 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | M Exercise deriv | 2007-01-23 | 2016-09-22 | 5,008 | — | $0 | 25,845 | SEC↗ |